Ultradent Adds 168,000 Sq. Ft. Facility to Campus

Posted on

Ultradent Products, Inc., a leading developer and manufacturer of high-tech dental materials and equipment, is unveiling a new 168,000 sq. ft. facility on its South Jordan campus.   The building’s grand opening will feature a 10am MST ribbon cutting on May 3, 2023. Ultradent’s leadership, along with South Jordan Mayor Dawn Ramsey, as well as […]

Read More

Clinical Study Results of the BlueWind System for Patients with Overactive Bladder Featured at the 2023 AUA Annual Meeting

Posted on

NEWS PROVIDED BY BlueWind Medical OASIS study achieves primary and secondary endpoints, safely mitigating the debilitating effects of urgency urinary incontinence Study results show that 78% of those implanted and 82% of patients completing the study achieved at least a 50% reduction in urge incontinence episodes at 12 months At 12 months, 50% of the […]

Read More

Bovine-specific ELISAs Now Available from Quansys Biosciences

Posted on

LOGAN, Utah—A new ELISA kit has been developed that can measure bovine and African Water Buffalo cytokines in plasma, serum, cell culture supernatants. The kit is a sensitive and accurate way to measure the levels of these important proteins, which play a role in a variety of diseases and conditions.  Cytokines are small proteins that are […]

Read More

BD Recognized by Forbes as a Best Employer for Diversity in 2023 List

Posted on

Accolade Represents Positive Perceptions from Employees and Progress in Advancing ESG Strategy FRANKLIN LAKES, N.J., April 25, 2023 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has been recognized by Forbes as one of the leading employers in the U.S.for diversity.   BD was named to […]

Read More

Oxford Nanopore and bioMérieux to enter into a strategic partnership agreement to develop innovative infectious disease diagnostics

Posted on

Oxford Nanopore Technologies and bioMérieux SA, a world leader in the field of in vitro diagnostics, today announced that they have teamed up to improve health outcomes globally by exploring selected opportunities to bring nanopore sequencing to the infectious disease diagnostics market.  The companies are jointly exploring selected opportunities to advance patient care by providing […]

Read More

ATL Technology Acquires Gyrus Medical LTD. Manufacturing Operations

ATL Technology (ATL), a fast-growing provider of outsourced design, development and manufacturing services to the medical device market, today announced it has acquired manufacturing operations of Gyrus Medical Limited (Gyrus/GML) from Olympus Winter & Ibe GmbH (Olympus Surgical Technologies Europe). Gyrus, located in Cardiff, Wales, United Kingdom, is also a device outsourcer and will increase […]

Read More

Utah State University President, Noelle Cockett, Visits Seek Labs

SALT LAKE CITY, APRIL 27, 2023 – Seek Labs, a healthcare innovation company, welcomed Utah State University (USU) President, Noelle Cockett, at the company’s office on Thursday, April 27. Seek Labs has an ongoing partnership with Utah State University and works closely with President Cockett to advance scientific research at Seek Labs and Utah State. During the […]

Read More

Xenocor Completes Oversubscribed $10 million Series A to Lead the Future of Laparoscopic Visualization

Led by GenHenn Venture Fund I, Xenocor will leverage the capital to facilitate launch and rapid adoption of the 5mm articulating Saberscope SALT LAKE CITY, April 18, 2023 /PRNewswire/ — Xenocor, creator of the FDA cleared Saberscope, the world’s first true HD, fog-free, articulating, single-use laparoscope, announced a $10 million Series A funding led by […]

Read More

New Published Real-World Evidence Shows KidneyIntelX™ Utility

Posted on

Real-World Utility Data Demonstrates KidneyIntelX Optimizes Clinical Management in Early-Stage Chronic Kidney Disease Across Multiple Physician Specialties KidneyIntelX individualizes clinical decisions beginning at primary care where impacts of new therapies, blood pressure strategies and timely referral can have maximal effect on outcomes and cost in patients with type 2 diabetes and chronic kidney disease LONDON […]

Read More